# Ian M. Thompson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ian-m-thompson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 64,425 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 114 |
| i10-index | 661 |
| Last Known Institution | The University of Texas at San Antonio Health Science Center |
| OpenAlex ID | https://openalex.org/A5015887484 |
| ORCID iD | https://orcid.org/0000-0003-0833-952X |
| Works | 1,626 |

## Researcher papers

- [Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci](https://scholariq.org/papers/association-analyses-of-more-than-140-000-men-identify-63-new-prostate-cancer/)
- [Intermittent versus Continuous Androgen Deprivation in Prostate Cancer](https://scholariq.org/papers/intermittent-versus-continuous-androgen-deprivation-in-prostate-cancer/)
- [Addressing overdiagnosis and overtreatment in cancer: a prescription for change](https://scholariq.org/papers/addressing-overdiagnosis-and-overtreatment-in-cancer-a-prescription-for-change/)
- [Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction](https://scholariq.org/papers/trans-ancestry-genome-wide-association-meta-analysis-of-prostate-cancer/)
- [Cardiovascular Safety of Testosterone-Replacement Therapy](https://scholariq.org/papers/cardiovascular-safety-of-testosterone-replacement-therapy/)
- [Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/circulating-tumor-cell-counts-are-prognostic-of-overall-survival-in-swog-s0421-a/)
- [The association of body mass index and prostate‐specific antigen in a population‐based study](https://scholariq.org/papers/the-association-of-body-mass-index-and-prostate-specific-antigen-in-a-population/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [The University of Texas at San Antonio Health Science Center](https://scholariq.org/institutions/the-university-of-texas-at-san-antonio-health-science-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.